002550.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China...

Stats
Dzisiejszy wolumen	22.99M
Średni wolumen	12.36M
Kapitalizacja rynkowa	6.81B
EPS	CNY0.0618 ( 2023-10-24 )
Następna data zysków	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	33.38
ATR14	CNY0.0100 (0.19%)

Wolumen Korelacja

Długi: -0.12 (neutral)

Krótki: -0.25 (neutral)

Signal:(37.392) Neutral

Changzhou Qianhong Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Changzhou Qianhong Korelacja - Waluta/Towar

-0.09
( neutral )

-0.40
( neutral )

0.00
( neutral )

0.51
( weak )

Changzhou Qianhong Finanse

Annual	2023
Przychody:	CNY1.81B
Zysk brutto:	CNY784.94M (43.26 %)
EPS:	CNY0.140

FY	2023
Przychody:	CNY1.81B
Zysk brutto:	CNY784.94M (43.26 %)
EPS:	CNY0.140

FY	2022
Przychody:	CNY2.30B
Zysk brutto:	CNY888.97M (38.59 %)
EPS:	CNY0.250

FY	2021
Przychody:	CNY1.87B
Zysk brutto:	CNY833.63M (44.46 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Changzhou Qianhong

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.